ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
  • Trust Score
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint745,701 companies indexed · Last updated: today
DirectoryIndustryMedical Technology IndustryBaselNeoPredics AG
NeoPredics AG Logo
Verified· 2 sourcesTrust Score
Summary

About the company

The core activity of NeoPredics is the development and provision of software solutions for the medical care of women and newborns, particularly in the field of perinatal and neonatal medicine. The software solutions are based on Predictive Analytics and aim to support clinical decision-making and provide personalized treatment solutions. Specifically, the company develops solutions such as BiliPredics, a predictive software for bilirubin values, and a preeclampsia prediction solution.

AI-generated
Offering

Products & services

Industry:Medical Technology Industry
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
4.1/5

NeoPredics AG

✓ Offered3
Prediction software for neonatal jaundice (BiliPredics)
Prediction of bilirubin trends in newborns, clinical decision support, risk stratification for hyperbilirubinemia, a web application with visualizations, PDF reports and EMR integration.
Predictive model for preeclampsia risks (PreFree)
Prediction of preeclampsia-associated risks, early risk stratification for pregnant women, a combination of biomarkers and clinical data, a digital patient diary and an app for clinical staff.
Clinical decision support with predictive analytics
Clinical decision support for women's and children's health, personalized solutions for earlier risk detection, scientifically validated predictions for medical professionals.
Trust & reputation

ranQ Trust Score of NeoPredics AG: 4.1 out of 5.0

Trust Score4.1/ 5.0

High

x

Data basis 54% · As of October 2026

Without public customer reviews the score stays capped.

NeoPredics AG has no value in the Reputation area of the ranQ Trust Score because no data is available. The area carries 42% of the weighting and drops out of the calculation for this profile; it does not lower the score, only the reported data basis.
x
CriterionValueWeight
  • Review quality: No data point — the criterion is taken out of the weighting and does not lower the score.—24%
  • Review volume: No data point — the criterion is taken out of the weighting and does not lower the score.—10%
  • Review recency: No data point — the criterion is taken out of the weighting and does not lower the score.—8%
NeoPredics AG scores 76.5 out of 100 points in the Substance area of the ranQ Trust Score. This area carries 28% of the weighting.
x
CriterionValueWeight
  • Establishment: Years since founding or brand launch, logarithmic. The maximum is reached at 15 years.70.212%
  • Company size: The headcount band, researched by ranQ or stated by the company. It is scored in steps rather than by head count, because the data only provides bands.70.07%
NeoPredics AG scores 83.3 out of 100 points in the Identity area of the ranQ Trust Score. This area carries 22% of the weighting.
x
CriterionValueWeight
  • Verification: Official register entry (commercial register with UID or professional-body record, 55 points), confirmed domain (20 points) and confirmed ranQ profile (up to 25 points, depending on completeness).83.322%
NeoPredics AG scores 100.0 out of 100 points in the Visibility area of the ranQ Trust Score. This area carries 8% of the weighting.
x
CriterionValueWeight
  • Website authority: Ahrefs' Domain Rating measures, on a scale of 0 to 100, how strongly a website is linked from other websites. For Swiss SMEs the range up to 40 is typical; the maximum is reached at 35.100.04%
  • Media authority: No data point — the criterion is taken out of the weighting and does not lower the score.—4%
Qualifications+0.00

NeoPredics AG reaches a ranQ Trust Score of 4.1 out of 5.0 — rated «High». No public customer reviews are available for this provider; the rating is based on the remaining criteria. The data basis is 54%, so the score is backed by part of the criteria. As of October 2026.

The Trust Score cannot be bought and is calculated from publicly verifiable data.

Knowledge

No knowledge articles yet

Once NeoPredics AG has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

NeoPredics AG in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank NeoPredics AG by reviews, experience and specialisations.

Is this your company?

Claim the company profile of NeoPredics AG to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Rittergasse 22
4051 Basel

At a glance

Legal form
Corporation
UID
CHE-303.160.239
Founded
2020 · 6 years
Last commercial register change
June 26, 2026
Employees
11 to 20
Legal form: Graded by liability and disclosure. The weight is kept small: a sole proprietorship is not a dubious company, it is just liable differently.
100.0
6%
  • Branch offices: Branch offices linked in the commercial register. Having none is normal and costs no points.70.03%
    • Full methodology

    Similar companies

    RS
    ResMed Schweiz GmbH
    Basel
    SL
    Scanderra LLB AG
    Basel
    AA
    ACTICORE AG
    Basel
    LS
    Lantheus Switzerland GmbH
    Basel
    MD
    MOMM Diagnostics AG
    Basel
    CT
    Chromatographic Technologies, Tetaz
    Basel
    SA
    Scailyte AG
    Basel
    IM
    Inari Medical Europe GmbH
    Basel